141113-98-6

Basic information

• Product Name: 4-BROMO-TOLUENE-3-SULFONYL CHLORIDE
• Synonyms: 4-BROMO-TOLUENE-3-SULFONYL CHLORIDE;4-BROMO-TOLENE-3-SULFONYL CHLORIDE;2-BroMo-5-Methylbenzene-1-sulfonyl chloride
• CAS NO: 141113-98-6
• Molecular Formula: C₇H₆BrClO₂S
• Molecular Weight: 269.54
• Mol File: 141113-98-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-BROMO-TOLUENE-3-SULFONYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-TOLUENE-3-SULFONYL CHLORIDE(141113-98-6)
• EPA Substance Registry System: 4-BROMO-TOLUENE-3-SULFONYL CHLORIDE(141113-98-6)

Safety Data

• Hazardous Substances Data: 141113-98-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-BROMO-TOLUENE-3-SULFONYL CHLORIDE is used as a synthetic intermediate for the development of various drugs. Its mild and selective oxidizing properties make it a valuable component in the synthesis of pharmaceutical compounds, contributing to the creation of novel therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 4-BROMO-TOLUENE-3-SULFONYL CHLORIDE is employed as a key ingredient in the production of pesticides. Its reactivity and ability to form sulfonamides facilitate the synthesis of effective pest control agents, enhancing crop protection and yield.
Used in Dye and Pigment Production:
4-BROMO-TOLUENE-3-SULFONYL CHLORIDE is used as a chemical intermediate in the manufacturing process of dyes and pigments. Its involvement in the synthesis of these colorants is crucial for producing a wide range of hues used in various industries, including textiles, plastics, and printing.
Used in Specialty Chemicals:
This sulfonyl chloride derivative is also utilized in the production of specialty chemicals, which are high-value compounds used in specific applications due to their unique properties. 4-BROMO-TOLUENE-3-SULFONYL CHLORIDE contributes to the development of these specialized products, expanding the capabilities and performance of various industrial processes.

Upstream product

• 106-38-7 para-bromotoluene 
• 56919-22-3 4-bromo-toluene-3-sulfonic acid 

Downstream Products

• 254897-02-4 1-bromo-4-(bromomethyl)-2-(methylsulfonyl)benzene 
• 254897-01-3 1-bromo-2-methanesulfonyl-4-methylbenzene 

Relevant articles and documents

A scaffold replacement approach towards new sirtuin 2 inhibitors

Sirtuins (SIRT1–SIRT7) are an evolutionary conserved family of NAD+-dependent protein deacylases regulating the acylation state of ε-N-lysine residues of proteins thereby controlling key biological processes. Numerous studies have found association of the aberrant enzymatic activity of SIRTs with various diseases like diabetes, cancer and neurodegenerative disorders. Previously, we have shown that substituted 2-alkyl-chroman-4-one/chromone derivatives can serve as selective inhibitors of SIRT2 possessing an antiproliferative effect in two human cancer cell lines. In this study, we have explored the bioisosteric replacement of the chroman-4-one/chromone core structure with different less lipophilic bicyclic scaffolds to overcome problems associated to poor physiochemical properties due to a highly lipophilic substitution pattern required for achieve a good inhibitory effect. Various new derivatives based on the quinolin-4(1H)-one scaffold, bicyclic secondary sulfonamides or saccharins were synthesized and evaluated for their SIRT inhibitory effect. Among the evaluated scaffolds, the benzothiadiazine-1,1-dioxide-based compounds showed the highest SIRT2 inhibitory activity. Molecular modeling studies gave insight into the binding mode of the new scaffold-replacement analogues.

Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them

The invention relates to compounds of formula (I), wherein the symbols have the meanings indicated in the specification. The inventive compounds exhibit dramatic antiarrhythmic proprieties and contain a cardioprotective compound. They can preventively inhibit or strongly reduce pathophysiologic processes upon occurrence of ischemic injuries, especially ischemic cardiac arrhythmia. Said compounds also exhibit a strong inhibiting effect on cellular proliferation.

Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament

The invention relates to compounds of the formula (I), in which the symbols have the following meaning: R(1) is 1. alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms; 2. alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms, in which one to all hydrogen atoms are replaced by fluorine; 3. alkenyl having 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms; or 4. —CnH2n?nn—Y, nn is zero or 2; and n is zero, 1, 2, 3 or 4; where n is unequal to zero or 1 if nn is equal to 2; 5. —CnH2n?nn—Y, nn is zero or 2; and n is 1, 2, 3 or 4; where n is unequal to 1 if nn is equal to 2.

Perfluoroalkyl-substituted, benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them

Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them A description is given of perfluoroalkyl-substituted benzoylguanidines of the formula I STR1 whe